Home  >  Products  >  ATP6V1C2 (ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 ) Blocking Peptide (the C terminal of ATP6V1C2)(100ug)
ATP6V1C2 (ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 ) Blocking Peptide (the C terminal of ATP6V1C2)(100ug)

ATP6V1C2 (ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 ) Blocking Peptide (the C terminal of ATP6V1C2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ATP6V1C2 Antibody (ARP62325_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62325
Size: 100ug
Weight: 42kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A,three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site. This gene encodes alternate transcriptional splice variants, encoding different V1 domain C subunit isoforms.
Alternative names: ATP6C2; VMA5
See Full Product Listings >